Table 2.
Delivery system | Nucleic acid | Cells/Model | Effects | Reference |
---|---|---|---|---|
Cationic lipid-based | ||||
DOTMA-based ether and DOTAP-based ester trichain | gWIZ-luciferase plasmid | B104 cells | • The third hydrophobic chain of at least 12 carbon had a substantial influence on lipid packing in the presence of DNA • Transfection efficacies of trichain lipids were found to be higher than dichain analogs |
[239] |
Cationic liposomes composed of DOTAP, DOPE and Cholesterol (3:4:3 molar ratio) | CYP1A1 siRNA | In vitro: A549 cells In vivo: A549 tumor-bearing BALB/c nude mice |
• Downregulation of CYP1A1 mRNA, protein, and enzymatic activity • Reduced in vivo tumor growth upon silencing of CYP1A1 gene |
[240] |
PEGylated cationic liposomes (PCL) composed of DOPE: POPC: Cholesterol: DC-6-14 (3:2:3:2 molar ratio) | pEGFP-N1 or siGFP | Male BALB/c mice (healthy mice), male BALB/c nude mice (T cell-deficient mice), and female MRL/lpr mice (SLE-prone mice) | • The intravenous injection of PCL-associated nucleic acids (pDNA or siRNA) induced anti-nucleic acids (IgM) in healthy mice but did not cause SLE and did not trigger lupus nephritis • PCL-associated nucleic acids might exacerbate SLE symptoms in SLE-prone mice with pre-existing anti-nuclear antibodies |
[241] |
Cationic polymer-based | ||||
Poly(3-hydroxybutyrate) (PHB)-co-PEI nanoparticles | miR-128-encoding plasmid | U87 cells | • Adequate protection of plasmid DNA against serum nucleases • Efficiently transfected U87 cells and initiated apoptosis |
[242] |
Low molecular weight PEI conjugated guar gum (GG-g-LPEI) | EGFP-N1 plasmid DNA | MDA-MB-231 and HeLa cells | • The GG-g-LPEI polymer displayed excellent biocompatibility and blood compatibility • The GG-g-LPEI polymer demonstrated high in vitro transfection efficiency in MDA-MB-231 cells |
[243] |
PLL-g-PEG polymer | HIF-1α plasmid | Healthy and diabetic rats | • PLL-g-PEG polymer effectively condensed plasmid DNA • PLL-g-PEG mediated HIF-1α delivery led to differential gene expression in vivo and initiated angiogenesis in cutaneous wounds |
[170] |
Methylated 4-N,N dimethyl aminobenzyl N,O carboxymethyl chitosan (MABCC), thiolated trimethyl chitosan (TMC-Cys), and thiolated trimethyl aminobenzyl chitosan (MABC-Cys) | EGFP-N1 plasmid | HEK-293T, SKOV-3, and MCF-7 cells | • All three polymers effectively condensed plasmid DNA at N/P ≥2, and polyplexes had negligible cytotoxicity • MABC-Cys exhibited the maximum gene expression in HEK-293T cells, while TMC-Cys was most effective in SKOV-3 and MCF-7 cells |
[244] |
Linoleic acid and penetratin dual-functionalized chitosan (CS-Lin-Pen) | gWiz-βGal and gWiz-GFP plasmids | HEK293, CHO, and HeLa cells | • Enhanced DNA protection, cell uptake, and endosomal escape • Improved gene transfection |
[245] |
Folate-conjugated amphiphilic cationic methoxy- poly(ethylene glycol)- b- poly(ε-caprolactone)- b- poly(ethylene imine) copolymer (MPEG–PCL–PEI-FA) | pLuc and Nur77 gene | HEK293 and HeLa/Bcl-2 cells | • MPEG-PCL-PEI-FA copolymer showed lower cytotoxicity and better gene transfection efficiency than PEI • Exhibited effective growth inhibition of therapeutic resistant HeLa/Bcl-2 cancer cells |
[246] |
Thiolated trimethylated chitosan/pDNA/folate conjugated cis-aconitic amide-PEI ternary complex (FA-PEI-AcO/TMC-SS/pDNA) | pEGFP | HeLa cells | • TMC-SS acquired good pDNA condensation and redox-responsive pDNA release. • FA-PEI-AcO/TMC-SS/pDNA demonstrated lowered cytotoxicity and enhanced gene transfection than TMC-SS/pDNA polyplexes in folate receptor positive tumor cells |
[247] |
TAT-functionalized PEI-grafting rice bran polysaccharides (PRBP-TAT) | EGFP plasmid | HEK293T, BRL, and HepG2 cells | • Effective DNA condensation and protection at low N/P ratio (i.e., 1–3.5) • PRBP-TAT showed lower cytotoxicity and higher gene transfection efficiency than PEI |
[80] |
Hydroxyl-rich poly (glycidyl methacrylate) (PGMA)-based cationic glycopolymers | EGFR-siRNA | HeLa cells | • The optimized formulation showed ∼52% knockdown efficiency • The polymer was found to be cytocompatible |
[248] |
Dendrimer-based | ||||
G5 PAMAM dendrimers, and L-PEI | GFP plasmid | HEK 293A cells | • pDNA loaded in cells using PAMAM dendrimer and endosomal release was mediated by L-PEI • The addition of L-PEI led to a 10-fold higher gene expression |
[249] |
Coumarin-anchored PAMAM dendrimers | TRAIL plasmid | MDA-MB-231 and HEK293 cells | • Light-responsive drug release behavior and light-enhanced anticancer activity • TRAIL plasmid and 5-Fu combination therapy resulted in improved anticancer activity |
[250] |
Polypeptide-based | ||||
Tat–RGD peptide | Fibroblasts (FB) and smooth muscle cells (SMC) derived from pulmonary arteries and A549 cells | • The improvement of DNA internalization by Tat–RGD polymer was primarily mediated by caveolae-dependent endocytosis • Efficient gene delivery to human pulmonary cells |
[204] | |
Inorganic nanoparticles | ||||
Carbon quantum dots (CQDs) | TGFβ1 plasmid | 3T6 cells | • CQDs played dual roles as gene vectors and bioimaging probes at the same time. • CQDs displayed strong DNA condensing capacity, good biocompatibility, and high transfection efficiency |
[251] |
Gold nanoparticles | pCMVp53 plasmid | In vitro: SKOV-3 cells In vivo: SKOV-3 tumor xenograft mouse model |
• The nanoparticle/pDNA complex was serum-stable and protected complexed pDNA from DNase-I digestion. • The nanoparticle/pDNA complex demonstrated considerable tumor targeting and tumor regression |
[252] |
Zwitterion-functionalized dendrimer-entrapped gold nanoparticles | pGFP and pLuc | HeLa cells | • Compaction of pDNA to form polyplexes • Effectively transfected cancer cells at an N/P ratio of 4 |
[253] |
Lipid nanoparticles | ||||
iRGD functionalized solid lipid nanoparticle | siPDL1 and siEGFR | In vitro: U87 and GL261 cells In vivo: orthotopic glioblastoma (GL261) xenograft mouse model |
• Nanoparticles provided efficient protection of siRNAs against the harsh biological environment • Significant tumor inhibition led to prolonged mouse survival |
[254] |
DOTMA: 1,2-di-O-octadecenyl-3-trimethylammonium propane; DOTAP: 1,2-dioleoyl-3-trimethylammonium propane; DOPE: 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine; POPC: 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; DC-6-14: O,O′-ditetradecanoyl-N-(alpha-trimethylammonio acetyl) diethanolamine chloride; SLE; systemic lupus erythematosus.